Apyx Medical (NASDAQ:APYX – Get Free Report) and Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.
Analyst Ratings
This is a summary of current ratings and recommmendations for Apyx Medical and Nihon Kohden, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Apyx Medical | 1 | 1 | 5 | 1 | 2.75 |
| Nihon Kohden | 0 | 2 | 0 | 0 | 2.00 |
Apyx Medical presently has a consensus price target of $6.50, suggesting a potential upside of 154.90%. Given Apyx Medical’s stronger consensus rating and higher probable upside, equities analysts clearly believe Apyx Medical is more favorable than Nihon Kohden.
Earnings & Valuation
This table compares Apyx Medical and Nihon Kohden”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Apyx Medical | $52.84 million | 2.03 | -$11.21 million | ($0.20) | -12.75 |
| Nihon Kohden | $1.56 billion | 1.13 | $95.79 million | $0.55 | 19.09 |
Nihon Kohden has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Nihon Kohden, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Apyx Medical has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500. Comparatively, Nihon Kohden has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500.
Institutional and Insider Ownership
55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 0.1% of Nihon Kohden shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Profitability
This table compares Apyx Medical and Nihon Kohden’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Apyx Medical | -14.78% | -76.60% | -13.91% |
| Nihon Kohden | 5.90% | 9.17% | 6.47% |
Summary
Apyx Medical beats Nihon Kohden on 8 of the 14 factors compared between the two stocks.
About Apyx Medical
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
About Nihon Kohden
Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers. In addition, it operates insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.
